D. Citron

发表

A central role for venom in predation by Varanus komodoensis (Komodo Dragon) and the extinct giant Varanus (Megalania) priscus

C. Clemente, M. V. van Osch, W. Teeuwisse, 2009, Proceedings of the National Academy of Sciences.

Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens

E. Goldstein, D. Citron, C. J. Alexander, 1995, Journal of clinical microbiology.

Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A7 2007

W. Gregory, N. Jacobus, D. Hecht, 2012 .

National hospital survey of anaerobic culture and susceptibility methods: III.

E. Goldstein, D. Citron, Pamela J Goldman, 2008, Anaerobe.

Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides

E. Goldstein, D. Citron, S. Hunt Gerardo, 1996, Antimicrobial agents and chemotherapy.

In vitro activity of eravacycline and comparator antimicrobials against 143 recent strains of Bacteroides and Parabacteroides species.

E. Goldstein, D. Citron, K. Tyrrell, 2018, Anaerobe.

In Vitro Activities of Doripenem and Six Comparator Drugs against 423 Aerobic and Anaerobic Bacterial Isolates from Infected Diabetic Foot Wounds

E. Goldstein, D. Citron, K. Tyrrell, 2007, Antimicrobial Agents and Chemotherapy.

Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents

Benjamin A Lipsky, E. Goldstein, D. Citron, 2007, Journal of Clinical Microbiology.

Comparative In Vitro Susceptibilities of 396 Unusual Anaerobic Strains to Tigecycline and Eight Other Antimicrobial Agents

E. Goldstein, D. Citron, Yumi A. Warren, 2006, Antimicrobial Agents and Chemotherapy.

Correspondence of In Vitro and In Vivo Fluconazole Dose-Response Curves for Cryptococcus neoformans

T. Harrison, D. Citron, R. Larsen, 2005, Antimicrobial Agents and Chemotherapy.

Dog bite wounds and infection: a prospective clinical study.

E. Goldstein, D. Citron, S. Finegold, 1980, Annals of emergency medicine.

Update on the taxonomy and clinical aspects of the genus fusobacterium.

D. Citron, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

J. Peters, J. Johansson, P. Crookes, 2007, Journal of Gastrointestinal Surgery.

Antimicrobial Resistance of Anaerobic Bacteria

E. Goldstein, D. Hecht, D. Citron, 2008 .

In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens.

E. Goldstein, D. Citron, K. Tyrrell, 2006, International journal of antimicrobial agents.

Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.

E. Goldstein, D. Citron, Yumi A. Warren, 2001, The Journal of antimicrobial chemotherapy.

Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.

E. Goldstein, D. Citron, M. Hudspeth, 1998, The Journal of antimicrobial chemotherapy.

How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay?

D. Citron, P. Appelbaum, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Selective and differential medium for isolation of Clostridium difficile

D. Citron, S. Finegold, V. Sutter, 1979, Journal of clinical microbiology.

Anaerobic bacteria cultured from the tongue dorsum of subjects with oral malodor.

E. Goldstein, D. Citron, Yumi A. Warren, 2003, Anaerobe.

Introduction of Ertapenem into a Hospital Formulary: Effect on Antimicrobial Usage and Improved In Vitro Susceptibility of Pseudomonas aeruginosa

V. Peraino, E. Goldstein, A. Meibohm, 2009, Antimicrobial Agents and Chemotherapy.

Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.

E. Cheek, D. Gerding, S. Sambol, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparative In Vitro Activity of Omadacycline against Dog and Cat Bite Wound Isolates

E. Goldstein, D. Citron, K. Tyrrell, 2018, Antimicrobial Agents and Chemotherapy.

Efficacy of bezlotoxumab in trial participants infected with Clostridioides difficile strain BI associated with poor outcomes.

D. Gerding, E. Goldstein, M. Wilcox, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Wadsworth Anaerobic Bacteriology Manual

D. Citron, S. Finegold, V. Sutter, 1980 .

In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections

E. Goldstein, D. Citron, K. Tyrrell, 2017, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Pexiganan and 10 Comparator Antimicrobials against 234 Isolates, Including 93 Pasteurella Species and 50 Anaerobic Bacterial Isolates Recovered from Animal Bite Wounds

E. Goldstein, D. Citron, K. Tyrrell, 2017, Antimicrobial Agents and Chemotherapy.

Comparison of the Copan eSwab System with an Agar Swab Transport System for Maintenance of Fastidious Anaerobic Bacterium Viability

E. Goldstein, D. Citron, K. Tyrrell, 2016, Journal of Clinical Microbiology.

Ceftaroline versus Isolates from Animal Bite Wounds: Comparative In Vitro Activities against 243 Isolates, Including 156 Pasteurella Species Isolates

E. Goldstein, D. Citron, K. Tyrrell, 2012, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria

E. Goldstein, D. Citron, K. Tyrrell, 2012, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species

E. Goldstein, D. Citron, K. Tyrrell, 2012, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Ceftazidime-NXL104 against 396 Strains of β-Lactamase-Producing Anaerobes

E. Goldstein, D. Citron, K. Tyrrell, 2011, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Dalbavancin and 12 Other Agents against 329 Aerobic and Anaerobic Gram-Positive Isolates Recovered from Diabetic Foot Infections

E. Goldstein, D. Citron, K. Tyrrell, 2006, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Moxifloxacin against 923 Anaerobes Isolated from Human Intra-Abdominal Infections

E. Goldstein, D. Citron, K. Tyrrell, 2006, Antimicrobial Agents and Chemotherapy.

Broth Microdilution and Disk Diffusion Tests for Susceptibility Testing of Pasteurella Species Isolated from Human Clinical Specimens

E. Goldstein, D. Citron, M. Goldstein, 2005, Journal of Clinical Microbiology.

In Vitro Activities of Dalbavancin and Nine Comparator Agents against Anaerobic Gram-Positive Species and Corynebacteria

E. Goldstein, D. Citron, K. Tyrrell, 2003, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Telithromycin and 10 Oral Agents against Aerobic and Anaerobic Pathogens Isolated from Antral Puncture Specimens from Patients with Sinusitis

E. Goldstein, D. Citron, Yumi A. Warren, 2003, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Garenoxacin (BMS-284756) against 170 Clinical Isolates of Nine Pasteurella Species

E. Goldstein, D. Citron, Yumi A. Warren, 2002, Antimicrobial Agents and Chemotherapy.

Periodontal Bacteria in Rabbit Mandibular and Maxillary Abscesses

E. Goldstein, D. Citron, K. Tyrrell, 2002, Journal of Clinical Microbiology.

In Vitro Activities of Garenoxacin (BMS 284756) against 108 Clinical Isolates of Gardnerella vaginalis

E. Goldstein, D. Citron, K. Tyrrell, 2002, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.

H. Teppler, E. Goldstein, M. Motyl, 2002, The Journal of antimicrobial chemotherapy.

Comparative In Vitro Activities of ABT-773 against Aerobic and Anaerobic Pathogens Isolated from Skin and Soft-Tissue Animal and Human Bite Wound Infections

E. Goldstein, D. Citron, Yumi A. Warren, 2000, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of GAR-936 against Aerobic and Anaerobic Animal and Human Bite Wound Pathogens

E. Goldstein, D. Citron, Yumi A. Warren, 2000, Antimicrobial Agents and Chemotherapy.

Survival of Aerobic and Anaerobic Bacteria in Purulent Clinical Specimens Maintained in the Copan Venturi Transystem and Becton Dickinson Port-a-Cul Transport Systems

E. Goldstein, D. Citron, M. Hudspeth, 2000, Journal of Clinical Microbiology.

Comparative In Vitro Activities of Amoxicillin-Clavulanate against Aerobic and Anaerobic Bacteria Isolated from Antral Puncture Specimens from Patients with Sinusitis

E. Goldstein, D. Citron, C. V. Merriam, 1999, Antimicrobial Agents and Chemotherapy.

Activity of Gatifloxacin Compared to Those of Five Other Quinolones versus Aerobic and Anaerobic Isolates from Skin and Soft Tissue Samples of Human and Animal Bite Wound Infections

E. Goldstein, D. Citron, Yumi A. Warren, 1999, Antimicrobial Agents and Chemotherapy.

Activities of Telithromycin (HMR 3647, RU 66647) Compared to Those of Erythromycin, Azithromycin, Clarithromycin, Roxithromycin, and Other Antimicrobial Agents against Unusual Anaerobes

E. Goldstein, D. Citron, K. Tyrrell, 1999, Antimicrobial Agents and Chemotherapy.

Linezolid Activity Compared to Those of Selected Macrolides and Other Agents against Aerobic and Anaerobic Pathogens Isolated from Soft Tissue Bite Infections in Humans

E. Goldstein, D. Citron, C. V. Merriam, 1999, Antimicrobial Agents and Chemotherapy.

In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans

E. Goldstein, D. Citron, M. Hudspeth, 1997, Antimicrobial agents and chemotherapy.

Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections

D. Citron, M. Appleman, 1997, Antimicrobial agents and chemotherapy.

Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates

E. Goldstein, D. Citron, C. Nesbit, 1995, Antimicrobial agents and chemotherapy.

Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents

E. Goldstein, D. Citron, E. J. Goldstein, 1993, Antimicrobial Agents and Chemotherapy.

Desulfovibrio desulfuricans Bacteremia and Review of Human Desulfovibrio Infections

V. Peraino, S. A. Cross, E. Goldstein, 2003, Journal of Clinical Microbiology.

Biochemical Differentiation and Comparison of Desulfovibrio Species and Other Phenotypically Similar Genera

E. Goldstein, D. Citron, C. V. Merriam, 2005, Journal of Clinical Microbiology.

Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus.

E. Goldstein, D. Citron, M. Rybak, 2008, Journal of medical microbiology.

Characterization of the Bacteroides fragilis pathogenicity island in human blood culture isolates.

E. Goldstein, A. Rodloff, D. Hecht, 2006, Anaerobe.

Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.

E. Goldstein, C. Inderlied, D. Citron, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Development of Tyrocidine A analogues with improved antibacterial activity.

Clay C C Wang, D. Citron, Clay C. C. Wang, 2007, Bioorganic & medicinal chemistry.

Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients.

D. C. Griffith, M. Dudley, D. Citron, 2010, Diagnostic microbiology and infectious disease.

In Vitro Activity of Ceftaroline against 623 Diverse Strains of Anaerobic Bacteria

E. Goldstein, D. Citron, K. Tyrrell, 2010, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp

E. Goldstein, D. Citron, Yumi A. Warren, 2004, Antimicrobial Agents and Chemotherapy.

EMERGEncy ID NET: Review of a 20-Year Multisite Emergency Department Emerging Infections Research Network

Stephen M. Rothrock, D. Karras, L. Slutsker, 2017, Open forum infectious diseases.

Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.

R. Goering, S. Sambol, Stuart Johnson, 2020, The Journal of antimicrobial chemotherapy.

Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006-2009 to 2012-2015.

D. Gerding, E. Goldstein, S. Sambol, 2018, Anaerobe.

MBX-500, a Hybrid Antibiotic with In Vitro and In Vivo Efficacy against Toxigenic Clostridium difficile

S. Tzipori, H. Feng, C. Kelly, 2012, Antimicrobial Agents and Chemotherapy.

Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom.

D. Gerding, K. Walker-Bone, M. Llewelyn, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection.

D. Gerding, E. Goldstein, S. Sambol, 2009, Anaerobe.

C. difficile infection (CDI) in a long-term acute care facility (LTAC).

E. Goldstein, D. Citron, Jessica Polonsky, 2009, Anaerobe.

PCR fingerprinting analysis for differentiation of Streptococcus pneumoniae reinfection versus relapse.

E. Goldstein, D. Citron, S. Hunt Gerardo, 2000, Diagnostic microbiology and infectious disease.

Toxin-producing bacteria in infants. Lack of an association with sudden infant death syndrome.

C. Langston, D. Citron, M. Gurwith, 1981, American journal of diseases of children.

Lactobacillus species: taxonomic complexity and controversial susceptibilities.

E. Goldstein, D. Citron, K. Tyrrell, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of Clostridium difficile minimum inhibitory concentrations obtained using agar dilution vs broth microdilution methods.

D. Citron, L. Chesnel, J. Nary, 2017, Anaerobe.

In Vitro Activity of Tedizolid Compared to Linezolid and Five Other Antimicrobial Agents against 332 Anaerobic Isolates, Including Bacteroides fragilis Group, Prevotella, Porphyromonas, and Veillonella Species

E. Goldstein, D. Citron, C. V. Merriam, 2020, Antimicrobial Agents and Chemotherapy.

Pre-molecular identification: ignorance was bliss?

D. Citron, 2012, Anaerobe.

Gram-negative anaerobic bacilli: Their role in infection and patterns of susceptibility to antimicrobial agents. II. Little-known Fusobacterium species and miscellaneous genera.

D. Citron, S. Finegold, V. Sutter, 1981, Reviews of infectious diseases.

Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.

E. Goldstein, G. Stein, D. Nicolau, 2008, Anaerobe.

Immunoblots, antimicrobial resistance, and bacteriophage typing of oxacillin-resistant Staphylococcus aureus

P. Smith, D. Citron, M. Mulligan, 1988, Journal of clinical microbiology.

Impact of prolonged incubation on disk diffusion susceptibility test results for Staphylococcus aureus

J. Hindler, D. Citron, M. Mulligan, 1987, Journal of clinical microbiology.

Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species.

D. Citron, S. Finegold, V. Sutter, 1980, Reviews of infectious diseases.

Comparative In Vitro Activities of Relebactam, Imipenem, the Combination of the Two, and Six Comparator Antimicrobial Agents against 432 Strains of Anaerobic Organisms, Including Imipenem-Resistant Strains

E. Goldstein, D. Citron, K. Tyrrell, 2017, Antimicrobial Agents and Chemotherapy.

Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1

J. R. Greenwood, M. J. Pickett, D. Citron, 1979, Journal of clinical microbiology.

A selective medium for Fusobacterium spp.

E. Goldstein, D. Citron, J. Brazier, 1991, The Journal of applied bacteriology.

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

E. Goldstein, D. Citron, 1992, Antimicrobial Agents and Chemotherapy.

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

D. Gerding, E. Goldstein, S. Sambol, 2011, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of Retapamulin (SB-275833) against 141 Clinical Isolates of Propionibacterium spp., Including 117 P. acnes Isolates

E. Goldstein, D. Citron, K. Tyrrell, 2006, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Daptomycin, Ciprofloxacin, and Other Antimicrobial Agents against the Cells and Spores of Clinical Isolates of Bacillus Species

D. Citron, M. Appleman, 2006, Journal of Clinical Microbiology.

In Vitro Activities of Nontraditional Antimicrobials against Multiresistant Acinetobacter baumannii Strains Isolated in an Intensive Care Unit Outbreak

H. Belzberg, T. Berne, P. Heseltine, 2000, Antimicrobial Agents and Chemotherapy.

Treatment of Clostridium difficile Infection With Tigecycline: Proof of Concept Study

E. Goldstein, G. Stein, V. Young, 2013 .

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria.

E. Goldstein, D. Citron, Yumi A. Warren, 2009, The Journal of antimicrobial chemotherapy.

Impact of cefoperazone therapy on fecal flora

D. Citron, M. Mulligan, S. Finegold, 1982, Antimicrobial Agents and Chemotherapy.

Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus

P. Ruane, D. Citron, M. Mulligan, 1986, Journal of clinical microbiology.

Activity of a novel carbapenem, doripenem, against anaerobic pathogens.

E. Goldstein, D. Citron, 2009, Diagnostic microbiology and infectious disease.

Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.

E. Goldstein, D. Citron, K. Tyrrell, 2008, Anaerobe.

Sequence conservation and distribution of the fusobacterial immunosuppressive protein gene, fipA.

E. Goldstein, S. Haake, D. Citron, 2002, Oral microbiology and immunology.

Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments.

E. Goldstein, D. Talan, G. Moran, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group.

E. Goldstein, D. Talan, G. Moran, 1999, The New England journal of medicine.

In Vitro Activities of Iodonium Salts against Oral and Dental Anaerobes

E. Goldstein, P. Stang, D. Citron, 2004, Antimicrobial Agents and Chemotherapy.

Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy

D. Citron, M. Mulligan, S. Finegold, 1984, Antimicrobial Agents and Chemotherapy.

Bacteriology of rattlesnake venom and implications for therapy.

E. Goldstein, D. Citron, S. Finegold, 1979, The Journal of infectious diseases.

Synergistes Group Organisms of Human Origin

E. Goldstein, H. Horz, D. Citron, 2006, Journal of Clinical Microbiology.

Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species

E. Goldstein, D. Citron, J. Brazier, 1990, Antimicrobial Agents and Chemotherapy.

Comparative phospholipid analogue distributions of Porphyromonas gingivalis isolated from cats in Australia and the USA.

A. Blinkhorn, E. Goldstein, M. Korachi, 2001, Veterinary microbiology.

In Vitro Activity of Biapenem plus RPX7009, a Carbapenem Combined with a Serine β-Lactamase Inhibitor, against Anaerobic Bacteria

E. Goldstein, D. Citron, K. Tyrrell, 2013, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Daptomycin, Vancomycin, Quinupristin- Dalfopristin, Linezolid, and Five Other Antimicrobials against 307 Gram-Positive Anaerobic and 31 Corynebacterium Clinical Isolates

E. Goldstein, D. Citron, C. V. Merriam, 2003, Antimicrobial Agents and Chemotherapy.

In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci.

D. Citron, M. Appleman, Y. Kwok, 2005, Anaerobe.

Evaluation of the E test for susceptibility testing of anaerobic bacteria

E. Goldstein, D. Citron, Margareta, 1991, Journal of clinical microbiology.

Comparative In Vitro Activities of Ertapenem (MK-0826) against 469 Less Frequently Identified Anaerobes Isolated from Human Infections

E. Goldstein, D. Citron, K. Tyrrell, 2002, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of Ertapenem (MK-0826) against 1,001 Anaerobes Isolated from Human Intra-Abdominal Infections

E. Goldstein, D. Citron, K. Tyrrell, 2000, Antimicrobial Agents and Chemotherapy.

Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract.

E. Goldstein, D. Citron, M. Corrado, 1987, The American journal of medicine.

Son of anaerobic susceptibility testing— Revisited

E. Baron, D. Citron, H. Wexler, 1990 .

Infections following clenched-fist injury: a new perspective.

E. Goldstein, D. Citron, S. Finegold, 1978, The Journal of hand surgery.

Resistance Trends in Antimicrobial Susceptibility of Anaerobic Bacteria, Part I

E. Goldstein, D. Citron, 2011 .

Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum.

E. Goldstein, D. Citron, S. Finegold, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Susceptibility testing of anaerobic bacteria: A review of current methods and future prospects

D. Citron, 1992 .

National hospital survey of anaerobic culture and susceptibility testing methods: results and recommendations for improvement

E. Goldstein, D. Citron, R. J. Goldman, 1992, Journal of clinical microbiology.

National Hospital SurveyofAnaerobic Culture andSusceptibility Testing Methods: Results andRecommendations forImprovement

D. Citron, 1992 .

Brain abscess and cerebritis.

D. Citron, S. Finegold, W. L. George, 1984, Reviews of infectious diseases.

Role of anaerobic bacteria in bite-wound infections.

E. Goldstein, D. Citron, S. Finegold, 1984, Reviews of infectious diseases.

Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.

E. Goldstein, D. Citron, 1996, The Journal of antimicrobial chemotherapy.

Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media.

D. E. Roe, J. Rosenblatt, E. Goldstein, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Multilaboratory comparison of growth characteristics for anaerobes, using 5 different agar media.

J. Rosenblatt, E. Goldstein, S. Jenkins, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

United States National Hospital Survey of anaerobic culture and susceptibility methods, II.

E. Goldstein, D. Citron, R. J. Goldman, 1995, Anaerobe.

Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile.

E. Goldstein, D. Citron, 2011, Diagnostic microbiology and infectious disease.

Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group

E. Goldstein, D. Citron, 1988, Journal of clinical microbiology.

Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus aureus

E. Goldstein, D. Citron, 1985, Antimicrobial Agents and Chemotherapy.

Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.

E. Goldstein, S. Hillier, D. Citron, 1993, The Journal of antimicrobial chemotherapy.

AnnualIncidence, Epidemiology, andComparative InVitro Susceptibilities toCefoxitin, Cefotetan, Cefmetazole, and Ceftizoxime ofRecentCommunity-Acquired Isolates ofthe

D. Citron, C. Goldstein, 1988 .

Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles.

E. Goldstein, G. Schönian, A. Rodloff, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Short prereduced anaerobically sterilized (PRAS) biochemical scheme for identification of clinical isolates of bile-resistant Bacteroides species

E. Baron, E. Goldstein, D. Citron, 1990, Journal of clinical microbiology.

ANAEROBIC AND AEROBIC BACTERIOLOGY OF THE SALIVA AND GINGIVA FROM 16 CAPTIVE KOMODO DRAGONS (VARANUS KOMODOENSIS): NEW IMPLICATIONS FOR THE “BACTERIA AS VENOM” MODEL

E. Goldstein, B. Fry, Cathleen R. Cox, 2013, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

Impact of Surotomycin on the Gut Microbiota of Healthy Volunteers in a Phase 1 Clinical Trial

E. Goldstein, D. Citron, L. Chesnel, 2016, Antimicrobial Agents and Chemotherapy.

Specimen collection and transport, anaerobic culture techniques, and identification of anaerobes.

D. Citron, 1984, Reviews of infectious diseases.

Anaerobic identification flowchart using minimal laboratory resources.

E. Baron, D. Citron, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates

E. Goldstein, D. Citron, M. Hudspeth, 1997, Antimicrobial agents and chemotherapy.

Pharmacokinetics and Pharmacodynamics of Linezolid in Obese Patients with Cellulitis

E. Goldstein, G. Stein, D. Citron, 2005, The Annals of pharmacotherapy.

Animal Bites

H. Meislin, E. Goldstein, L. Baraff, 1985, JACEP.

The conundrum of the gram-positive rod: are we missing important pathogens in complicated skin and soft-tissue infections? A case report and review of the literature.

D. Citron, S. Towfigh, Tatyan Clarke, 2010, Surgical infections.

Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases

E. Goldstein, D. Citron, Catherine A Nesbit, 1996, Diabetes Care.

16S-23S rRNA gene internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Porphyromonas.

E. Goldstein, H. Horz, D. Citron, 2005, International journal of systematic and evolutionary microbiology.

Bilophila wadsworthia clinical isolates compared by polymerase chain reaction fingerprinting.

E. Goldstein, D. Citron, M. Hudspeth, 1997, Clinical Infectious Diseases.

Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.

E. Goldstein, D. Citron, K. Tyrrell, 2002, Journal of Antimicrobial Chemotherapy.

In Vitro Activities of Ramoplanin, Teicoplanin, Vancomycin, Linezolid, Bacitracin, and Four Other Antimicrobials against Intestinal Anaerobic Bacteria

E. Goldstein, D. Citron, K. Tyrrell, 2003, Antimicrobial Agents and Chemotherapy.

General microbiology and in vitro susceptibility of anaerobes isolated from complicated skin and skin-structure infections in patients enrolled in a comparative trial of ertapenem versus piperacillin-tazobactam.

E. Goldstein, R. Gesser, D. Citron, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Survival of anaerobic bacteria in various thioglycolate and chopped meat broth formulations

E. Goldstein, D. Citron, M. Claros, 1995, Journal of clinical microbiology.

Difficulty in the identification and differentiation of clinically relevant Ochrobactrum species.

E. Goldstein, P. Kämpfer, D. Citron, 2007, Journal of medical microbiology.

Pelvic Abscess Due to Ochrobactrum anthropi in an Immunocompetent Host: Case Report and Review of the Literature

E. Goldstein, D. Citron, Sagar A. Vaidya, 2006, Journal of Clinical Microbiology.

Pelvic Abscess Due to Ochrobactrum anthropi in an Immunocompetent Host: Case Report and Review of the Literature

E. Goldstein, D. Citron, Sagar A. Vaidya, 2006, Journal of Clinical Microbiology.

Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates.

M. Trousdale, D. Citron, M. Appleman, 1987, Archives of ophthalmology.

Frequency of isolation of Porphyromonas species from infected dog and cat bite wounds in humans and their characterization by biochemical tests and arbitrarily primed-polymerase chain reaction fingerprinting.

E. Goldstein, D. Talan, D. Citron, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds

E. Goldstein, D. Citron, 1988, Antimicrobial Agents and Chemotherapy.

Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida

Goldstein, E. Goldstein, G. Richwald, 1988, Antimicrobial Agents and Chemotherapy.

Susceptibility of bite wound bacteria to seven oral antimicrobial agents, including RU-985, a new erythromycin: considerations in choosing empiric therapy

E. Goldstein, D. Citron, S. Finegold, 1986, Antimicrobial Agents and Chemotherapy.

Pasteurellamultocida subsp.multocida and P. multocida subsp.septica Differentiation by PCR Fingerprinting and α-Glucosidase Activity

E. Goldstein, D. Citron, S. Hunt Gerardo, 2001, Journal of Clinical Microbiology.

16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Fusobacterium.

E. Goldstein, D. Citron, M. Claros, 2002, International journal of systematic and evolutionary microbiology.

Growth characteristics and a novel method for identification (the WEE-TAB system) of Porphyromonas species isolated from infected dog and cat bite wounds in humans

E. Goldstein, D. Citron, M. Hudspeth, 1997, Journal of clinical microbiology.

Mobilization and prevalence of a Fusobacterial plasmid.

E. Goldstein, S. Haake, Brian Claypool, 2010, Plasmid.

Fusobacterium canifelinum sp. nov., from the oral cavity of cats and dogs.

E. Goldstein, D. Citron, R. Mutters, 2004, Systematic and applied microbiology.

Immunoblot characterization of Porphyromonas species from infected dog and cat bite wounds in humans.

E. Goldstein, D. Citron, M. Mulligan, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Evaluation of the RapID CB Plus System for Identification of Corynebacterium Species and Other Gram-Positive Rods

E. Goldstein, D. Citron, M. Hudspeth, 1998, Journal of Clinical Microbiology.

E. Goldstein, D. Citron, J. Brazier, 1995, Journal of clinical microbiology.

Antibacterial activity of crotalid venoms against oral snake flora and other clinical bacteria.

E. Goldstein, D. Talan, G. Overturf, 1991, The Journal of infectious diseases.

Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

E. Goldstein, J. Solomkin, D. Citron, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Efﬁcacy and Correlation of Clinical Outcomes With In Vitro Susceptibility for Anaerobic Bacteria in Patients With Complicated Intra-abdominal Infections Treated With Moxiﬂoxacin

E. Goldstein, J. Solomkin, D. Citron, 2011 .

Review of the Comparative In vitro Susceptibilities of Lower Female Genital Tract Pathogens to Older and Newer Fluoroquinolones

E. Goldstein, A. Decherney, D. Citron, 2000 .

Activity of garenoxacin against 536 unusual anaerobes including 128 recovered from acute pelvic infections.

E. Goldstein, D. Citron, K. Tyrrell, 2011, Diagnostic microbiology and infectious disease.

Two Novel Vaginal Microbicides (Polystyrene Sulfonate and Cellulose Sulfate) Inhibit Gardnerella vaginalis and Anaerobes Commonly Associated with Bacterial Vaginosis

Robert A. Anderson, L. Zaneveld, D. Citron, 2002, Antimicrobial Agents and Chemotherapy.

Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals

E. Goldstein, D. Citron, 1985, Antimicrobial Agents and Chemotherapy.

Recovery of an unusual Flavobacterium group IIb-like isolate from a hand infection following pig bite

M. J. Pickett, E. Goldstein, D. Citron, 1990, Journal of clinical microbiology.

Susceptibility of Eikenella corrodens to penicillin, apalcillin, and twelve new cephalosporins

E. Goldstein, D. Citron, 1984, Antimicrobial Agents and Chemotherapy.

Bacteriology of human and animal bite wounds

E. Goldstein, D. Citron, S. Finegold, 1978, Journal of clinical microbiology.

Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin.

D. Citron, A. Barry, P. Fuchs, 1993, The Journal of antimicrobial chemotherapy.

Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole

E. Goldstein, D. Citron, 1991, Antimicrobial Agents and Chemotherapy.

Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.

F. Greenway, D. Citron, R. Kahn, 1987, The American journal of medicine.

Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteria.

E. Goldstein, D. Citron, 1988, Clinical therapeutics.

Simian bites and bacterial infection.

E. Goldstein, D. Citron, E. P. Pryor, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Peptoniphilus coxii sp. nov. and Peptoniphilus tyrrelliae sp. nov. isolated from human clinical infections.

E. Goldstein, D. Citron, K. Tyrrell, 2012, Anaerobe.

Characterization of Bacteroides forsythus Strains from Cat and Dog Bite Wounds in Humans and Comparison with Monkey and Human Oral Strains

E. Goldstein, D. Citron, M. Hudspeth, 1999, Journal of Clinical Microbiology.

Comparative In Vitro Activities of XRP 2868, Pristinamycin, Quinupristin-Dalfopristin, Vancomycin, Daptomycin, Linezolid, Clarithromycin, Telithromycin, Clindamycin, and Ampicillin against Anaerobic Gram-Positive Species, Actinomycetes, and Lactobacilli

E. Goldstein, D. Citron, A. Bryskier, 2005, Antimicrobial Agents and Chemotherapy.

Cefoxitin for treatment of infections due to anaerobic bacteria.

D. Busch, D. Citron, S. Finegold, 1979, Reviews of infectious diseases.

Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitals

E. Goldstein, D. Citron, 1986, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Daptomycin, Vancomycin, and Penicillin against Clostridium difficile, C. perfringens, Finegoldia magna, and Propionibacterium acnes

E. Goldstein, D. Citron, K. Tyrrell, 2006, Antimicrobial Agents and Chemotherapy.

Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.

P. Lawson, D. Citron, S. Finegold, 2016, Anaerobe.

Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations

E. Goldstein, D. Citron, C. Cherubin, 1991, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals

E. Goldstein, D. Citron, 1985, Antimicrobial Agents and Chemotherapy.

Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group

E. Goldstein, D. Citron, C. Cherubin, 1991, Antimicrobial Agents and Chemotherapy.

Bacteriology of a Bear Bite Wound to a Human: Case Report

E. Goldstein, R. Rennie, D. Citron, 2004, Journal of Clinical Microbiology.

Novel Bacterium Isolated from a Lung Transplant Patient with Cystic Fibrosis

B. Bochner, D. Citron, R. Barbers, 1999, Journal of Clinical Microbiology.

Clostridium difficile Infection Among US Emergency Department Patients With Diarrhea and No Vomiting

E. Goldstein, D. Talan, G. Moran, 2017, Annals of emergency medicine.

Antimicrobial Activities of Fidaxomicin

E. Goldstein, D. Citron, F. Babakhani, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridium aldenense sp. nov. and Clostridium citroniae sp. nov. Isolated from Human Clinical Infections

E. Goldstein, D. Citron, K. Tyrrell, 2006, Journal of Clinical Microbiology.

Effects of control interventions on Clostridium difficile infection in England: an observational study

Daniel J. Wilson, X. Didelot, T. Peto, 2017, The Lancet. Infectious diseases.

Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.

E. Goldstein, R. Carman, D. Citron, 2007, Anaerobe.

Evaluation of Cycloserine-Cefoxitin Fructose Agar (CCFA), CCFA with Horse Blood and Taurocholate, and Cycloserine-Cefoxitin Mannitol Broth with Taurocholate and Lysozyme for Recovery of Clostridium difficile Isolates from Fecal Samples

E. Goldstein, D. Citron, K. Tyrrell, 2013, Journal of Clinical Microbiology.

Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin

D. Gerding, E. Goldstein, S. Sambol, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vitro Activities of ABT-773, a New Ketolide, against Aerobic and Anaerobic Pathogens Isolated from Antral Sinus Puncture Specimens from Patients with Sinusitis

E. Goldstein, D. Citron, K. Tyrrell, 2001, Antimicrobial Agents and Chemotherapy.

Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial

D. Armstrong, Benjamin A Lipsky, D. Citron, 2005, The Lancet.

Structure-Activity Relationship Studies of a Series of Semisynthetic Lipopeptides Leading to the Discovery of Surotomycin, a Novel Cyclic Lipopeptide Being Developed for the Treatment of Clostridium difficile-Associated Diarrhea.

L. Mortin, M. Mesleh, D. Citron, 2015, Journal of medicinal chemistry.

Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient

E. Goldstein, D. Strollo, D. Citron, 2003, Transplant infectious disease : an official journal of the Transplantation Society.

Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.

D. Citron, M. Appleman, 2010, Diagnostic microbiology and infectious disease.

Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibaculum rodentium.

P. Lawson, M. Blaser, E. Goldstein, 2017, International journal of systematic and evolutionary microbiology.

Corrigendum: Description of two novel members of the family Erysipelotrichaceae: Ileibacterium valens gen. nov., sp. nov. and Dubosiella newyorkensis, gen. nov., sp. nov., from the murine intestine, and emendation to the description of Faecalibacterium rodentium.

P. Lawson, M. Blaser, E. Goldstein, 2017, International journal of systematic and evolutionary microbiology.

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence

E. Goldstein, D. Citron, K. Tyrrell, 2013, Antimicrobial Agents and Chemotherapy.

Comparative In Vitro Activities of GSK2251052, a Novel Boron-Containing Leucyl-tRNA Synthetase Inhibitor, against 916 Anaerobic Organisms

E. Goldstein, D. Citron, K. Tyrrell, 2013, Antimicrobial Agents and Chemotherapy.

Evaluation of the Velogene Genomic Assay for Detection of vanA and vanB Genes in Vancomycin-Resistant Enterococcus Species

D. Citron, M. Appleman, R. Kwok, 2004, Journal of Clinical Microbiology.

Bacteriology of human bite wound infections.

E. Goldstein, D. Citron, K. Tyrrell, 2003, Anaerobe.

In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

E. Goldstein, D. Citron, K. Tyrrell, 2002, Diagnostic microbiology and infectious disease.

In Vitro Activities of ABT-492, a New Fluoroquinolone, against 155 Aerobic and 171 Anaerobic Pathogens Isolated from Antral Sinus Puncture Specimens from Patients with Sinusitis

E. Goldstein, D. Citron, Ellie J. C. Goldstein, 2003, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Ceftobiprole against Aerobic and Anaerobic Strains Isolated from Diabetic Foot Infections

E. Goldstein, D. Citron, K. Tyrrell, 2006, Antimicrobial Agents and Chemotherapy.

Comparative in vitro activities of dalbavancin and seven comparator agents against 41 Staphylococcus species cultured from osteomyelitis infections and 18 VISA and hVISA strains.

E. Goldstein, D. Citron, K. Tyrrell, 2014, Diagnostic microbiology and infectious disease.

Multi-drug resistant Bacteroides fragilis recovered from blood and severe leg wounds caused by an improvised explosive device (IED) in Afghanistan.

Jeffrey E Sherwood, D. Citron, S. Patrick, 2011, Anaerobe.

New medium selective for Fusobacterium species and differential for Fusobacterium necrophorum

D. Citron, S. Finegold, A. Morgenstein, 1981, Journal of clinical microbiology.

Ridinilazole: a novel therapy for Clostridium difficile infection.

K. Garey, E. Goldstein, M. Wilcox, 2016, International journal of antimicrobial agents.

Bacterial counts from five over-the-counter probiotics: are you getting what you paid for?

E. Goldstein, D. Citron, M. Claros, 2014, Anaerobe.

Comparative In Vitro Activities of ABT-773 against 362 Clinical Isolates of Anaerobic Bacteria

D. Citron, M. Appleman, 2001, Antimicrobial Agents and Chemotherapy.

Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.

E. Goldstein, D. Citron, C. V. Merriam, 2009, Surgical infections.

Fusobacteria behaving badly: Masquerading strains of strictly anaerobic Escherichia coli misidentified due to the deletion of the hemB gene.

K. Garey, E. Goldstein, D. Citron, 2022, Anaerobe.

Genetic Determinant of Intrinsic Quinolone Resistance in Fusobacterium canifelinum

E. Goldstein, D. Citron, G. Conrads, 2005, Antimicrobial Agents and Chemotherapy.

Characterization of a beta-lactamase from Clostridium clostridioforme.

E. Goldstein, A. Philippon, D. Citron, 1994, Journal of Antimicrobial Chemotherapy.

Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.

E. Goldstein, D. Citron, K. Tyrrell, 2013, Diagnostic microbiology and infectious disease.

Comparative In Vitro Activities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates

E. Goldstein, D. Citron, K. Tyrrell, 2013, Antimicrobial Agents and Chemotherapy.

Changes in the antibiotic susceptibility of anaerobic bacteria from 2007-2009 to 2010-2012 based on the CLSI methodology.

Maria Karlsson, Audrey N Schuetz, L. Koeth, 2016, Anaerobe.

Jonquetella anthropi gen. nov., sp. nov., the first member of the candidate phylum 'Synergistetes' isolated from man.

K. Bernard, B. Gay, D. Citron, 2007, International journal of systematic and evolutionary microbiology.

In vitro stability of three oral vancomycin preparations stored at 2- 5 °C and ambient room temperature for up to 60 days against 100 Clostridioides (Clostridium) difficile and 51Staphylococcus aureus strains.

E. Goldstein, D. Citron, K. Tyrrell, 2018, Anaerobe.

Susceptibility of Eikenella corrodens to newer and older quinolones

D. Citron, M. Gombert, E. Goldstein, 1986, Antimicrobial Agents and Chemotherapy.

Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: 12-Month Observational Data From the Randomized Phase III Trial, MODIFY II.

D. Gerding, E. Goldstein, M. Wilcox, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Serious infection with Leptotrichia buccalis. Report of a case and review of the literature.

D. Citron, S. Finegold, A. Morgenstein, 1980, The American journal of medicine.

Impact of Cefoperazone Therapy

D. Citron, M. Mulligan, M. Sydney, 2022 .

Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods.

E. Goldstein, D. Citron, K. Tyrrell, 2011, Anaerobe.

In vitro activity of 11 antibiotics against 74 anaerobes isolated from pediatric intra-abdominal infections.

E. Goldstein, D. Citron, K. Tyrrell, 2006, Anaerobe.

Bactericidal Activities of Methoxyfluoroquinolones Gatifloxacin and Moxifloxacin against Aerobic and Anaerobic Respiratory Pathogens in Serum

E. Goldstein, G. Stein, D. Citron, 2003, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of the Des-Fluoro(6) Quinolone BMS-284756 against Aerobic and Anaerobic Pathogens Isolated from Skin and Soft Tissue Animal and Human Bite Wound Infections

E. Goldstein, D. Citron, Yumi A. Warren, 2002, Antimicrobial Agents and Chemotherapy.

Serum Bactericidal Activity of Trovafloxacin Against Selected Anaerobic Pathogens

E. Goldstein, G. Stein, D. Citron, 2001 .

Activities of Gemifloxacin (SB 265805, LB20304) Compared to Those of Other Oral Antimicrobial Agents against Unusual Anaerobes

E. Goldstein, D. Citron, K. Tyrrell, 1999, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Gemifloxacin (SB 265805) against Anaerobes

E. Goldstein, D. Citron, K. Tyrrell, 1999, Antimicrobial Agents and Chemotherapy.

Identification and strain differentiation of 'Bacteroides fragilis group' species and Prevotella bivia by PCR fingerprinting.

E. Goldstein, G. Schönian, A. Rodloff, 1995, Anaerobe.

In Vitro Activities of CB-183,315, Vancomycin, and Metronidazole against 556 Strains of Clostridium difficile, 445 Other Intestinal Anaerobes, and 56 Enterobacteriaceae Species

E. Goldstein, D. Citron, K. Tyrrell, 2011, Antimicrobial Agents and Chemotherapy.

Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.

E. Goldstein, G. Schönian, A. Rodloff, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial Vaginosis Anaerobes Commonly Associated with and Gardnerella vaginalis Sulfate) Inhibit (Polystyrene Sulfonate and Cellulose Two Novel Vaginal Microbicides

A. Robert, L. Zaneveld, D. Citron, 2014 .

The underappreciated in vitro activity of tedizolid against Bacteroides fragilis species, including strains resistant to metronidazole and carbapenems.

E. Goldstein, D. Citron, K. Tyrrell, 2017, Anaerobe.

Characterization of saccharolytic Bacteroides and Prevotella isolates from infected dog and cat bite wounds in humans

E. Goldstein, D. Talan, D. Citron, 1997, Journal of Clinical Microbiology.

anaerobic bite wound isolates. ciprofloxacin against 387 aerobic and levofloxacin, ofloxacin, sparfloxacin, and Comparative in vitro activities of DU-6859a,

E. Goldstein, D. Citron, M. Hudspeth, 2013 .

Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline

Samir N. Patel, Clinical, S. Richter, 2006 .

E. Goldstein, D. Citron, Kerin L. Tyrrella, 2014 .

Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.

E. Goldstein, G. Stein, D. Citron, 2007, International journal of antimicrobial agents.

In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis.

E. Goldstein, D. Citron, K. Tyrrell, 2005, Anaerobe.

Rapid Identification of Anaerobes in the Clinical Laboratory

D. Citron, 1999 .

In Vitro Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic, against 377 Strains of Anaerobic Bacteria and 34 Strains of Corynebacterium Species

E. Goldstein, D. Citron, Yumi A. Warren, 2012, Antimicrobial Agents and Chemotherapy.

Bacteriology of Moderate-to-Severe Diabetic Foot Infections and In Vitro Activity of Antimicrobial Agents

Benjamin A Lipsky, E. Goldstein, D. Citron, 2007, Journal of Clinical Microbiology.

Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.

E. Goldstein, D. Citron, C. V. Merriam, 2009, Surgical infections.

E. Goldstein, D. Citron, M. Rybak, 2008, Journal of medical microbiology.

Empyema due to Bacteroides gracilis: case report and in vitro susceptibilities to eight antimicrobial agents.

E. Goldstein, D. Citron, D. Lee, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.